BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1953670)

  • 1. Apoprotein-independent binding of chylomicron remnants to rat liver membranes.
    Borensztajn J; Kotlar TJ; Chang SY
    Biochem J; 1991 Nov; 279 ( Pt 3)(Pt 3):769-73. PubMed ID: 1953670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver uptake of chylomicron remnants with high and low apoprotein E:C ratios.
    Borensztajn J; Kotlar TJ
    Proc Natl Acad Sci U S A; 1984 Sep; 81(18):5863-6. PubMed ID: 6592590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The apoprotein B-independent hepatic uptake of chylomicron remnants.
    Borensztajn J; Getz GS; Padley RJ; Kotlar TJ
    Biochem J; 1982 May; 204(2):609-12. PubMed ID: 7115352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of rat chylomicrons and their remnants to the hepatic low-density-lipoprotein receptor and its role in remnant removal.
    Windler EE; Greeve J; Daerr WH; Greten H
    Biochem J; 1988 Jun; 252(2):553-61. PubMed ID: 3415673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of lipoprotein lipase and apoprotein E in the recognition of chylomicrons and chylomicron remnants by cultured isolated mouse hepatocytes.
    Chang S; Maeda N; Borensztajn J
    Biochem J; 1996 Aug; 318 ( Pt 1)(Pt 1):29-34. PubMed ID: 8761448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of low density lipoprotein receptor-dependent and -independent sites in binding and uptake of chylomicron remnants in rat liver.
    Nagata Y; Chen J; Cooper AD
    J Biol Chem; 1988 Oct; 263(29):15151-8. PubMed ID: 3170577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of chylomicron remnant binding to rat liver membranes.
    Cooper AD; Erickson SK; Nutik R; Shrewsbury MA
    J Lipid Res; 1982 Jan; 23(1):42-52. PubMed ID: 6799601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-binding apoproteins. Effects on lipoprotein lipase and hepatic uptake of remnants.
    Borensztajn J; Kotlar TJ; Matza CA
    Biochem J; 1986 Feb; 233(3):909-12. PubMed ID: 3707534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake of chylomicron remnants by the liver: further evidence for the modulating role of phospholipids.
    Borensztajn J; Getz GS; Kotlar TJ
    J Lipid Res; 1988 Aug; 29(8):1087-96. PubMed ID: 3183520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The uptake of chylomicron remnants and very low density lipoprotein remnants by the perfused rat liver.
    Arbeeny CM; Rifici VA
    J Biol Chem; 1984 Aug; 259(15):9662-6. PubMed ID: 6086643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of binding and removal of remnants of triglyceride-rich lipoproteins of intestinal and hepatic origin by rat liver in vitro.
    Cooper AD; Shrewsbury MA; Erickson SK
    Am J Physiol; 1982 Nov; 243(5):G389-95. PubMed ID: 7137355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic fate of chylomicron phospholipids and apoproteins in the rat.
    Tall AR; Green PH; Glickman RM; Riley JW
    J Clin Invest; 1979 Oct; 64(4):977-89. PubMed ID: 225354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of high density lipoproteins in regulation of hepatic fatty acid synthesis by chylomicron and very low density lipoprotein remnants.
    Lakshmanan MR; Maten MV; Muesing RA; O'Looney P; Vahouny GV
    J Biol Chem; 1983 Apr; 258(8):4746-9. PubMed ID: 6833273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipids as modulators of hepatic recognition of chylomicron remnants. Observations with emulsified lipoprotein lipids.
    Borensztajn J; Kotlar TJ
    Biochem J; 1990 Jul; 269(2):539-42. PubMed ID: 2386491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver.
    Windler E; Havel RJ
    J Lipid Res; 1985 May; 26(5):556-65. PubMed ID: 4020294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Action of liproprotein lipase on apoprotein-depleted chylomicrons.
    Lukens TW; Borensztajn J
    Biochem J; 1978 Oct; 175(1):53-61. PubMed ID: 216349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the hepatic removal of chylomicron remnants and beta-very low density lipoproteins in the rat.
    Jäckle S; Rinninger F; Greeve J; Greten H; Windler E
    J Lipid Res; 1992 Mar; 33(3):419-29. PubMed ID: 1569389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Composition, removal and metabolic fate of chylomicrons derived from diabetic rats.
    Levy E; Shafrir E; Ziv E; Bar-On H
    Biochim Biophys Acta; 1985 May; 834(3):376-85. PubMed ID: 3995073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic uptake of phospholipid-depleted chylomicrons in vivo. Comparison with the uptake of chylomicron remnants.
    Borensztajn J; Kotlar TJ
    Biochem J; 1981 Dec; 200(3):547-53. PubMed ID: 7342969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High affinity binding of chylomicron remnants to rat liver plasma membranes.
    Carrella M; Cooper AD
    Proc Natl Acad Sci U S A; 1979 Jan; 76(1):338-42. PubMed ID: 284350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.